SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001596783-24-000033
Filing Date
2024-05-08
Accepted
2024-05-08 16:23:50
Documents
105
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ctlt-20240331.htm   iXBRL 10-Q 1714429
2 EX-10.2 catalent-20240331xex102.htm EX-10.2 32902
3 EX-10.3 catalent-20240331xex103.htm EX-10.3 136491
4 EX-31.1 catalent-20240331xex311.htm EX-31.1 11056
5 EX-31.2 catalent-20240331xex312.htm EX-31.2 11012
6 EX-32.1 catalent-20240331xex321.htm EX-32.1 4521
7 EX-32.2 catalent-20240331xex322.htm EX-32.2 4245
13 ctlt-20240331_g1.jpg GRAPHIC 45267
14 ctlt-20240331_g2.jpg GRAPHIC 49523
15 ctlt-20240331_g3.jpg GRAPHIC 33956
16 ctlt-20240331_g4.jpg GRAPHIC 29931
17 ctlt-20240331_g5.jpg GRAPHIC 49283
18 ctlt-20240331_g6.jpg GRAPHIC 30697
19 ctlt-20240331_g7.jpg GRAPHIC 26539
20 image1a.jpg GRAPHIC 11897
21 image2.jpg GRAPHIC 12589
22 imagea.jpg GRAPHIC 31164
23 lesig.jpg GRAPHIC 5622
  Complete submission text file 0001596783-24-000033.txt   10026012

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ctlt-20240331.xsd EX-101.SCH 74567
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ctlt-20240331_cal.xml EX-101.CAL 83064
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ctlt-20240331_def.xml EX-101.DEF 374995
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ctlt-20240331_lab.xml EX-101.LAB 742604
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ctlt-20240331_pre.xml EX-101.PRE 644524
109 EXTRACTED XBRL INSTANCE DOCUMENT ctlt-20240331_htm.xml XML 1204239
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36587 | Film No.: 24926566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)